Paper1757079
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
Elston CW and 1 other. Histopathology, 1991. Cited by 4,895 papers, by iCite.
Cite this record
ConductScience Library. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Papers, record 1757079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1757079
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Follow-Up Studies | |
| Histological Techniques | |
| Humans | |
| Mitotic Index | |
| Neoplasm Recurrence, Local | |
| Prognosis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03917082 | Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Reprinted in | 12405947 | Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. | https://conductscience.org/library/papers/12405947 | PubMed |
| Comment in | 12405945 | Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403-410. | https://conductscience.org/library/papers/12405945 | PubMed |
Cited by1,987
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,895 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972452 | Multicenter development and validation of a serum microRNA-based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control study. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42972452 | PubMed |
| 42964509 | Label- and Slide-Free Multispectral Quantitative Epi-Illumination Deep-Ultraviolet Microscopy. | BME Front | 2026 | https://conductscience.org/library/papers/42964509 | PubMed |
| 42954225 | Molecular Subtypes and Treatment Modalities in Breast Cancer in a Brazilian Military Hospital: An Observational Study. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42954225 | PubMed |
| 42929994 | Immune- and Stromal-Associated Tissue-Context Profiles in Pretreatment Triple-Negative Breast Cancer: An Exploratory Institutional Cohort Study. | Diseases | 2026 | https://conductscience.org/library/papers/42929994 | PubMed |
| 42923317 | Immunohistochemical Expression of Proliferating Cell Nuclear Antigen in Invasive Breast Carcinoma: Associations With Histological Grade and Ki-67 Expression. | Cureus | 2026 | https://conductscience.org/library/papers/42923317 | PubMed |
| 42897655 | Do new guidelines enable a more accurate comparison of [18F]FDG PET/CT features with histopathology in primary breast cancer? | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42897655 | PubMed |
| 42883719 | Lipid Composition in the Breast of Premenopausal BRCA1/2 Genetic Mutation Carriers Using MRI. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883719 | PubMed |
| 42882846 | Histological Subtype Provides Limited Prognostic Information in Grade 1 Invasive Breast Carcinoma: A Retrospective Cohort Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882846 | PubMed |
| 42882793 | Transfer Learning-Based Quantification of Mitotic Activity and Its Prognostic and Molecular Associations in Lung Squamous Cell Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882793 | PubMed |
| 42855725 | Accurate assessment of surgical HER2-low status based on core needle biopsy data of breast cancer. | Diagn Progn Res | 2026 | https://conductscience.org/library/papers/42855725 | PubMed |
| 42844328 | ESR1 mutations are associated with enhanced MTORC1 signaling in a context-dependent manner. | Commun Biol | 2026 | https://conductscience.org/library/papers/42844328 | PubMed |
| 42793819 | Concordance of Digital Breast Tomosynthesis (DBT) and Magnetic Resonance Imaging (MRI) Measured Tumor Size with the Pathological Gold Standard: A Retrospective Cohort Analysis by Molecular Subtype and Breast Density. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42793819 | PubMed |
| 42787006 | Contralateral Primary Small-Cell Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation in a Patient With Prior Invasive Ductal Carcinoma: A Rare Case. | Cureus | 2026 | https://conductscience.org/library/papers/42787006 | PubMed |
| 42763585 | Histomorphological and Immunohistochemical Profile of Malignant Breast Lesions in a Tertiary Care Center of Central India: A Cross-Sectional Study. | Cureus | 2026 | https://conductscience.org/library/papers/42763585 | PubMed |
| 42718887 | The PROM1+SMAD5+ Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42718887 | PubMed |
| 42717518 | Serum Levels of Thyroid Hormones in Relation to Breast Cancer Prognosis: A Multicentre Cohort Study. | Cancer Med | 2026 | https://conductscience.org/library/papers/42717518 | PubMed |
| 42701629 | Prognostic value of ultrasound Breast Imaging Reporting and Data System for disease-free survival in early-stage breast cancer: a retrospective study (2011-2018). | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42701629 | PubMed |
| 42699720 | Immunohistochemical Expression of Programmed Death-Ligand 1 (PD-L1) in Breast Carcinoma and Its Correlation With Estrogen Receptor, Progesterone Receptor and HER2/neu Status: A Single-Centre Study From Central India. | Cureus | 2026 | https://conductscience.org/library/papers/42699720 | PubMed |
| 42687344 | 1H HR-MAS NMR Metabolomics in Combination With Transcriptomic Correlation Provides New Insights Into Metabolic Heterogeneity Across Breast Cancer Immunohistochemical Subtypes. | NMR Biomed | 2026 | https://conductscience.org/library/papers/42687344 | PubMed |
| 42680767 | A human epithelial cell cycle dataset. | Sci Data | 2026 | https://conductscience.org/library/papers/42680767 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1757079
GET https://conductscience.org/api/papers/v1/1757079/cited_by?page=2